person · Reporting owner

JOHNS MICHAEL M E

Disclosed activity across 2 companies

Tapewire entity: 12634
SEC CIK: 0001221096

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AMN HEALTHCARE SERVICES INCAMN · Entity 4780	Director	April 21, 2021	April 23, 2021
JOHNSON & JOHNSONJNJ · Entity 2722	Director	February 10, 2014	February 12, 2014

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AMN HEALTHCARE SERVICES INC

Report date April 21, 2021 · Filed April 23, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	89,269	Ending reported balance After 2021-04-21 transaction · row 9 9 source rows · reconciled sequence Row 1 · 2021-04-21 · Exercise / conversion · Acquired 2,826 · Balance 42,826 F1: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Row 2 · 2021-04-21 · Exercise / conversion · Acquired 2,153 · Balance 44,979 F2: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2018. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Row 3 · 2021-04-21 · Exercise / conversion · Acquired 3,365 · Balance 48,344 F3: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2017. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Row 4 · 2021-04-21 · Exercise / conversion · Acquired 3,793 · Balance 52,137 F4: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 20, 2016. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Row 5 · 2021-04-21 · Exercise / conversion · Acquired 5,532 · Balance 57,669 F5: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 22, 2015. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Row 6 · 2021-04-21 · Exercise / conversion · Acquired 10,490 · Balance 68,159 F6: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 23, 2014. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Row 7 · 2021-04-21 · Exercise / conversion · Acquired 9,563 · Balance 77,722 F7: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 13, 2010. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Row 8 · 2021-04-21 · Exercise / conversion · Acquired 9,563 · Balance 87,285 F8: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 9, 2009. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Row 9 · 2021-04-21 · Exercise / conversion · Acquired 1,984 · Balance 89,269 F9: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on December 23, 2008. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2021-04-21 · Exercise / conversion · Disposed 2,826 · Balance 0 F10: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F11: The RSUs were granted on April 24, 2013 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2014 Annual Meeting of Shareholders. F12: RSUs do not have an expiration date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2021-04-21 · Exercise / conversion · Disposed 2,153 · Balance 0 F10: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F13: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. F12: RSUs do not have an expiration date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2021-04-21 · Exercise / conversion · Disposed 3,365 · Balance 0 F14: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F15: The RSUs were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2018 Annual Meeting of Shareholders. F12: RSUs do not have an expiration date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2021-04-21 · Exercise / conversion · Disposed 3,793 · Balance 0 F14: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F16: The RSUs were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2017 Annual Meeting of Shareholders. F12: RSUs do not have an expiration date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2021-04-21 · Exercise / conversion · Disposed 5,532 · Balance 0 F14: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F17: The RSUs were granted on April 22, 2015 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2016 Annual Meeting of Shareholders. F12: RSUs do not have an expiration date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2021-04-21 · Exercise / conversion · Disposed 10,490 · Balance 0 F14: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F18: The RSUs were granted on April 23, 2014 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2015 Annual Meeting of Shareholders. F12: RSUs do not have an expiration date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2021-04-21 · Exercise / conversion · Disposed 9,563 · Balance 0 F14: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F19: The RSUs were granted on April 13, 2010 and vested in three tranches on the first, second and third anniversaries of the grant date. F12: RSUs do not have an expiration date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2021-04-21 · Exercise / conversion · Disposed 9,563 · Balance 0 F14: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F20: The RSUs were granted on April 9, 2009 and vested in three tranches on the first, second and third anniversaries of the grant date. F12: RSUs do not have an expiration date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-04-21 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2021-04-21 · Exercise / conversion · Disposed 1,984 · Balance 0 F14: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F21: The RSUs were granted on April 8, 2008 and vested in three tranches on the first, second and third anniversaries of the grant date. F12: RSUs do not have an expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

F2: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2018. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

F3: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2017. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

F4: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 20, 2016. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

F5: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 22, 2015. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

F6: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 23, 2014. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

F7: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 13, 2010. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

F8: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 9, 2009. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

F9: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on December 23, 2008. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

F10: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F11: The RSUs were granted on April 24, 2013 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2014 Annual Meeting of Shareholders.

F12: RSUs do not have an expiration date.

F13: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders.

F14: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F15: The RSUs were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2018 Annual Meeting of Shareholders.

F16: The RSUs were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2017 Annual Meeting of Shareholders.

F17: The RSUs were granted on April 22, 2015 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2016 Annual Meeting of Shareholders.

F18: The RSUs were granted on April 23, 2014 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2015 Annual Meeting of Shareholders.

F19: The RSUs were granted on April 13, 2010 and vested in three tranches on the first, second and third anniversaries of the grant date.

F20: The RSUs were granted on April 9, 2009 and vested in three tranches on the first, second and third anniversaries of the grant date.

F21: The RSUs were granted on April 8, 2008 and vested in three tranches on the first, second and third anniversaries of the grant date.

JOHNSON & JOHNSON

Report date February 10, 2014 · Filed February 12, 2014

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Deferred Share UnitsSEC Table II · derivative / convertible security	Direct	21,068	Reported balance After 2014-02-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2014-02-10 · Grant · Acquired 1,713 · Balance 21,068 F2: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
Common StockSEC Table I · non-derivative	Direct	15,290	Reported balance Holding disclosure · report date 2014-02-10 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 15,290 F1: Includes 3,331 shares held under the Issuer's Dividend Reinvestment Program.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 3,331 shares held under the Issuer's Dividend Reinvestment Program.

F2: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	1,984	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 18 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,984 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F21 · derivative.exercise_date: The RSUs were granted on April 8, 2008 and vested in three tranches on the first, second and third anniversaries of the grant date. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	9,563	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 17 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F20 · derivative.exercise_date: The RSUs were granted on April 9, 2009 and vested in three tranches on the first, second and third anniversaries of the grant date. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	9,563	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 16 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F19 · derivative.exercise_date: The RSUs were granted on April 13, 2010 and vested in three tranches on the first, second and third anniversaries of the grant date. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	10,490	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 15 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,490 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F18 · derivative.exercise_date: The RSUs were granted on April 23, 2014 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2015 Annual Meeting of Shareholders. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	5,532	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 14 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,532 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F17 · derivative.exercise_date: The RSUs were granted on April 22, 2015 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2016 Annual Meeting of Shareholders. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	3,793	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 13 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F16 · derivative.exercise_date: The RSUs were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2017 Annual Meeting of Shareholders. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	3,365	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 12 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F15 · derivative.exercise_date: The RSUs were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2018 Annual Meeting of Shareholders. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	2,153	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 11 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,153 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F13 · derivative.exercise_date: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	2,826	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · derivative · entry 10 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F11 · derivative.exercise_date: The RSUs were granted on April 24, 2013 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2014 Annual Meeting of Shareholders. F12 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	1,984	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 9 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on December 23, 2008. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	9,563	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 8 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 9, 2009. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	9,563	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 7 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 13, 2010. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	10,490	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 6 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 23, 2014. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	5,532	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 5 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 22, 2015. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	3,793	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 4 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 20, 2016. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	3,365	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 3 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2017. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	2,153	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2018. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors. Read SEC document
April 21, 2021 Filed Apr 23, 2021 19:20 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	2,826	$0.00	$0.00	Disclosure SEC source: 0001209191-21-028091 · doc4.xml · nonDerivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document
May 28, 2020 Filed Jun 1, 2020 20:45 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	SaleCommon Stock	2,907	$47.65	$138,518.55	Disclosure SEC source: 0001209191-20-033223 · doc4.xml · nonDerivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Read SEC document
April 22, 2020 Filed Apr 24, 2020 17:57 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	GrantRestricted Stock Units · Derivative	2,826	$0.00	$0.00	Disclosure SEC source: 0001209191-20-025568 · doc4.xml · derivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 22, 2020 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2021 Annual Meeting of Shareholders. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document
April 17, 2020 Filed Apr 21, 2020 20:03 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionRestricted Stock Units · Derivative	2,907	$0.00	$0.00	Disclosure SEC source: 0001209191-20-025212 · doc4.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders. Accordingly, the number of RSUs identified in this row vested on April 17, 2020. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 17, 2020 Filed Apr 21, 2020 20:03 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	Exercise / conversionCommon Stock	2,907	$0.00	$0.00	Disclosure SEC source: 0001209191-20-025212 · doc4.xml · nonDerivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document
November 04, 2019 Filed Nov 6, 2019 21:51 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	SaleCommon Stock	2,659	$59.88	$159,216.40	Disclosure SEC source: 0001209191-19-055514 · doc4.xml · nonDerivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · price: The price reported in this row represents a weighted average price of $59.8783 per share. These shares were sold in multiple transactions at prices ranging from $59.87 to $59.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document
June 14, 2019 Filed Jun 18, 2019 22:39 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	SaleCommon Stock	1,000	$51.85	$51,848.90	Disclosure SEC source: 0001209191-19-037802 · doc4.xml · nonDerivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,659 Read SEC document
April 17, 2019 Filed Apr 19, 2019 21:32 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	GrantRestricted Stock Units · Derivative	2,907	$0.00	$0.00	Disclosure SEC source: 0001209191-19-025402 · doc4.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,907 Underlying: Common Stock · 2,907 shares Expires not disclosed F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
February 21, 2019 Filed Apr 19, 2019 21:32 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	GiftCommon Stock	2,759	$0.00	$0.00	Disclosure SEC source: 0001209191-19-025402 · doc4.xml · nonDerivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,659 F1 · kind: The reporting person transferred 2,759 shares of AMN Common Stock as a gift to charity. Read SEC document
April 18, 2018 Filed Apr 20, 2018 20:45 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	GrantRestricted Stock Units · Derivative	2,153	$0.00	$0.00	Disclosure SEC source: 0001209191-18-025728 · doc4.xml · derivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,153 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. At the reporting person's irrevocable election, the number of RSUs identified in this row (i.e., 2,153) settle on the date of the director's termination of service with the Company. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document
April 18, 2017 Filed Apr 20, 2017 17:51 UTC	AMN HEALTHCARE SERVICES INC AMN · Entity 4780	GrantRestricted Stock Units · Derivative	3,365	$0.00	$0.00	Disclosure SEC source: 0001209191-17-027641 · doc4.xml · derivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 Underlying: Common Stock · 3,365 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. At the reporting person's irrevocable election, the number of Restricted Stock Units identified in this row (i.e. 3,365) settle on the date of the director's termination of service with the Company. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document
February 10, 2014 Filed Feb 12, 2014 23:26 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	1,713	$0.00	$0.00	Disclosure SEC source: 0000200406-14-000022 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,068 Underlying: Common Stock · 1,713 shares Expires not disclosed F2 · security: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_price: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
December 10, 2013 Filed Dec 12, 2013 20:35 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherDeferred Share Units · Derivative	133	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000120 · edgar.xml · derivative · entry 3 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,355 Underlying: Common Stock · 133 shares Expires not disclosed F3 · derivative.exercise_price: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · derivative.exercise_date: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · derivative.expiration_date: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
December 10, 2013 Filed Dec 12, 2013 20:35 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	292	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000120 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,222 Underlying: Common Stock · 292 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
September 10, 2013 Filed Sep 12, 2013 22:30 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherDeferred Share Units · Derivative	140	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000099 · edgar.xml · derivative · entry 3 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,930 Underlying: Common Stock · 140 shares Expires not disclosed F3 · derivative.exercise_price: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · derivative.exercise_date: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · derivative.expiration_date: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
September 10, 2013 Filed Sep 12, 2013 22:30 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	315	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000099 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,790 Underlying: Common Stock · 315 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
June 11, 2013 Filed Jun 13, 2013 18:52 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherDeferred Share Units · Derivative	139	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000071 · edgar.xml · derivative · entry 3 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,475 Underlying: Common Stock · 139 shares Expires not disclosed F3 · derivative.exercise_price: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · derivative.exercise_date: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · derivative.expiration_date: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
June 11, 2013 Filed Jun 13, 2013 18:52 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	323	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000071 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,336 Underlying: Common Stock · 323 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
March 12, 2013 Filed Mar 14, 2013 19:48 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherDeferred Share Units · Derivative	137	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000043 · edgar.xml · derivative · entry 3 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,013 Underlying: Common Stock · 137 shares Expires not disclosed F3 · derivative.exercise_price: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · derivative.exercise_date: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · derivative.expiration_date: Dividends accrued under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Share Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
March 12, 2013 Filed Mar 14, 2013 19:48 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	352	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000043 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,876 Underlying: Common Stock · 352 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
February 11, 2013 Filed Feb 13, 2013 20:13 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	1,926	$0.00	$0.00	Disclosure SEC source: 0000200406-13-000026 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,524 Underlying: Common Stock · 1,926 shares Expires not disclosed F2 · derivative.exercise_price: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Shares Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Shares Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: Grant of Deferred Share Units issued to Non-Employee Directors under the Issuer's Amended and Restated Deferred Fee Plan for Directors. Deferred Shares Units are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
December 11, 2012 Filed Dec 13, 2012 23:46 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	520	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000153 · edgar.xml · derivative · entry 3 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,598 Underlying: Common Stock · 520 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
December 11, 2012 Filed Dec 13, 2012 23:46 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherDeferred Share Units · Derivative	116	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000153 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,078 Underlying: Common Stock · 116 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · kind: Adjustment due to calculation error. F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
September 11, 2012 Filed Sep 13, 2012 17:31 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	571	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000127 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,194 Underlying: Common Stock · 571 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
June 12, 2012 Filed Jun 14, 2012 20:05 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	616	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000093 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,623 Underlying: Common Stock · 616 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F3 · balance_after: The prior report erroneously indicated 140,007 instead of 14,007. Read SEC document
March 13, 2012 Filed Mar 15, 2012 18:32 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	580	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000043 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,007 Underlying: Common Stock · 580 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
February 13, 2012 Filed Feb 16, 2012 00:41 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantDeferred Share Units · Derivative	694	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000029 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,427 Underlying: Common Stock · 694 shares Expires not disclosed F3 · security: Grant of Deferred Share Units issued to Non-Employee Directors under Issuer's Deferred Fee Plan for Directors. F4 · derivative.exercise_price: 1 for 1 F5 · derivative.exercise_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F5 · derivative.expiration_date: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document
February 13, 2012 Filed Feb 16, 2012 00:41 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantCommon Stock	1,543	Not disclosed	Not disclosed	Disclosure SEC source: 0000200406-12-000029 · edgar.xml · nonDerivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,356 F1 · price: Annual grant of Restricted Stock issued to Non-Employee Directors under Issuer's Long-Term Incentive Plan. F2 · balance_after: Includes 2,397 shares held under the Issuer's Dividend Reinvestment Program. Read SEC document
December 13, 2011 Filed Dec 15, 2011 22:38 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantPhantom Stock Units · Derivative	579	$0.00	$0.00	Disclosure SEC source: 0000200406-11-000125 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,733 Underlying: Common Stock · 579 shares Expires not disclosed F2 · security: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on December 13, 2011 at $63.78 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. F3 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on December 13, 2011 at $63.78 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. F2 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on December 13, 2011 at $63.78 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. Read SEC document
September 13, 2011 Filed Sep 15, 2011 16:05 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherPhantom Stock Units · Derivative	582	$0.00	$0.00	Disclosure SEC source: 0000200406-11-000104 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,154 Underlying: Common Stock · 582 shares Expires not disclosed F2 · security: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on September 13, 2011 at $62.95 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. F3 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on September 13, 2011 at $62.95 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. F2 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on September 13, 2011 at $62.95 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. Read SEC document
June 14, 2011 Filed Jun 15, 2011 16:47 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherPhantom Stock Units · Derivative	563	$0.00	$0.00	Disclosure SEC source: 0000200406-11-000073 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,572 Underlying: Common Stock · 563 shares Expires not disclosed F2 · security: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on June 14, 2011 at $66.62 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. F3 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on June 14, 2011 at $66.62 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. F2 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on June 14, 2011 at $66.62 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. Read SEC document
March 15, 2011 Filed Mar 16, 2011 18:34 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherPhantom Stock Units · Derivative	622	$0.00	$0.00	Disclosure SEC source: 0000200406-11-000041 · edgar.xml · derivative · entry 2 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,009 Underlying: Common Stock · 622 shares Expires not disclosed F2 · security: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on March 15, 2011 at $59.20 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. F3 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on March 15, 2011 at $59.20 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. F2 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Non-Employee Director Deferred Fee Plan on March 15, 2011 at $59.20 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. Read SEC document
February 15, 2011 Filed Feb 17, 2011 22:46 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantCommon Stock	1,650	Not disclosed	Not disclosed	Disclosure SEC source: 0000200406-11-000027 · edgar.xml · nonDerivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,387 F1 · price: Annual grant of Restricted Stock issued to Non-Employee Directors under Issuer's Long-Term Incentive Plan. F2 · balance_after: Includes 1,971 shares held under the Issuer's Dividend Reinvestment Program. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.